Promethazine: Expert Relief for Severe Nausea and Allergic Reactions
| Product dosage: 25mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 60 | $0.72 | $43.19 (0%) | 🛒 Add to cart |
| 90 | $0.69 | $64.79 $62.28 (4%) | 🛒 Add to cart |
| 120 | $0.67 | $86.38 $80.36 (7%) | 🛒 Add to cart |
| 180 | $0.66 | $129.57 $118.53 (9%) | 🛒 Add to cart |
| 270 | $0.65 | $194.36 $174.77 (10%) | 🛒 Add to cart |
| 360 | $0.64
Best per pill | $259.15 $229.01 (12%) | 🛒 Add to cart |
Synonyms | |||
Promethazine is a versatile phenothiazine-derived medication primarily indicated for the management of severe nausea, vomiting, and allergic conditions. It functions as a potent antihistamine (H1-receptor antagonist) with additional antiemetic, sedative, and anticholinergic properties, making it a valuable tool in both acute and prophylactic therapeutic regimens. Its efficacy is well-documented across clinical settings, from postoperative care to motion sickness and urticaria. This expert guide details its pharmacological profile, appropriate use, and essential safety information for healthcare professionals and informed patients.
Features
- Pharmacological Class: Phenothiazine derivative, first-generation antihistamine (H1-receptor antagonist)
- Available Forms: Oral tablets, syrup, suppositories, and injectable solution
- Mechanism of Action: Antagonizes histamine H1 receptors; depresses the medullary chemoreceptor trigger zone; possesses significant anticholinergic and sedative effects
- Onset of Action: Oral: ~20 minutes; IV: ~3–5 minutes; IM: ~20 minutes
- Duration of Effect: 4–6 hours for antiemetic effects; up to 12 hours for sedation
- Metabolism: Hepatic, primarily via CYP2D6 and CYP2B6 isoenzymes
- Elimination Half-life: Approximately 9–16 hours
Benefits
- Provides rapid and effective relief from severe nausea and vomiting, including postoperative, chemotherapy-induced, and vertigo-related symptoms
- Offers potent antihistaminic action for acute allergic reactions, such as urticaria, angioedema, and anaphylaxis (as an adjunct)
- Induces sedation, beneficial for preoperative anxiolysis, insomnia, or adjunctive treatment in agitated states
- Useful as an anti-motion sickness agent for prophylactic and acute treatment
- Demonstrates adjunctive efficacy in managing migraine-associated symptoms due to its antiemetic and sedative properties
- Cost-effective and widely available in multiple formulations for flexible administration
Common use
Promethazine is commonly prescribed for the prevention and treatment of nausea and vomiting associated with anesthesia, surgery, chemotherapy, radiation therapy, and motion sickness. It is also indicated for the management of allergic conditions such as allergic rhinitis, conjunctivitis, and mild allergic skin reactions. Off-label uses include sedation for procedures, adjunctive treatment in migraine headaches, and management of breakthrough nausea in palliative care. Its use in perennial and seasonal allergic rhinitis is well-established, though newer, less sedating antihistamines are often preferred for chronic management.
Dosage and direction
Dosage must be individualized based on indication, patient age, and clinical response.
Adults:
- Nausea/Vomiting: Oral/rectal: 12.5–25 mg every 4–6 hours as needed. IM/IV: 12.5–25 mg; may repeat every 4–6 hours.
- Allergy: Oral/rectal: 12.5 mg at bedtime or 6.25–12.5 mg three times daily.
- Sedation: Oral/IM/IV: 25–50 mg at bedtime or preoperatively.
Children (≥2 years): - Nausea/Vromiting/Allegy: Oral/rectal/IM: 0.25–0.5 mg/kg/dose (max 25 mg) every 4–6 hours.
- Sedation: Oral/IM: 0.5–1 mg/kg (max 50 mg).
Administration Notes: Avoid intra-arterial or subcutaneous injection due to risk of severe tissue injury. IV administration should be slow, diluted, and given through a running IV line into a large vein to minimize risk of chemical irritation and thrombosis.
Precautions
Use with caution in patients with respiratory depression, asthma, COPD, or sleep apnea due to potential for further respiratory suppression. Avoid use in patients with narrow-angle glaucoma, prostatic hypertrophy, or bladder neck obstruction due to anticholinergic effects. May impair mental and physical abilities; caution against operating machinery or driving. Elderly patients are at increased risk for sedation, confusion, and anticholinergic side effects. Use during pregnancy only if clearly needed (Category C). Excreted in breast milk; not recommended during lactation. Risk of severe tissue injury with improper injection (prefer deep IM injection; avoid SC/IA).
Contraindications
Hypersensitivity to promethazine or other phenothiazines. Comatose states, CNS depression due to alcohol, barbiturates, opioids, or other sedatives. Use in children under 2 years of age is contraindicated due to potential for fatal respiratory depression. Avoid in patients with severe hepatic impairment. Do not use in patients with suspected or established Reye’s syndrome due to theoretical risk of exacerbation.
Possible side effect
Common side effects include drowsiness, sedation, dizziness, blurred vision, dry mouth, and constipation. Less frequently, patients may experience hypotension, tachycardia, extrapyramidal symptoms (e.g., dystonia, akathisia), confusion, or photosensitivity. Rare but serious adverse effects include neuroleptic malignant syndrome, agranulocytosis, seizures, and respiratory depression. Injection site reactions (pain, necrosis, thrombophlebitis) may occur with parenteral administration.
Drug interaction
Potentiates CNS depression with alcohol, benzodiazepines, opioids, sedative-hypnotics, and other psychotropic agents. Concurrent use with MAO inhibitors may prolong and intensify anticholinergic effects. May antagonize the effects of dopamine agonists (e.g., levodopa). CYP2D6 inhibitors (e.g., fluoxetine, quinidine) may increase promethazine levels. Anticholinergic toxicity may be enhanced with other anticholinergic drugs. May mask symptoms of ototoxic drugs (e.g., aminoglycosides).
Missed dose
If a dose is missed, administer as soon as remembered unless it is nearly time for the next dose. Do not double the dose to make up for a missed one. For as-needed use, resume normal dosing schedule with the next required dose.
Overdose
Symptoms of overdose include severe CNS depression (coma, respiratory depression), hypotension, tachycardia, anticholinergic effects (dry mouth, flushed skin, hyperthermia), agitation, hallucinations, and seizures. Treatment is supportive and symptomatic: maintain airway, administer activated charcoal if recent ingestion, manage hypotension with IV fluids and vasopressors, control seizures with benzodiazepines. Avoid stimulants (may exacerbate seizures). Hemodialysis is not effective. Contact poison control immediately.
Storage
Store at controlled room temperature (20–25°C or 68–77°F). Protect from light and moisture. Keep oral solutions and tablets in tightly closed containers. Do not freeze. Keep all medications out of reach of children and pets. Do not use discolored solutions or tablets.
Disclaimer
This information is for educational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider for diagnosis and individualized treatment recommendations. Do not initiate, adjust, or discontinue medication without professional supervision. The prescriber should be aware of all potential risks, especially regarding route of administration and patient-specific factors.
Reviews
Clinical studies and meta-analyses consistently support the efficacy of promethazine in managing postoperative nausea and vomiting, with a number needed to treat (NNT) of 3–5. Its sedative properties are considered beneficial in specific contexts, though its side effect profile necessitates careful patient selection. Many clinicians regard it as a effective second-line option for breakthrough nausea or where cost is a significant factor. Parental reports in pediatric use (for indicated ages) often note effectiveness for motion sickness, though sedation is a common drawback. Overall, it remains a clinically relevant agent within its defined therapeutic niche.